REPLIGEN CORP Deferred Income Tax Expense (Benefit)
REPLIGEN CORP (RGEN) reported Deferred Income Tax Expense (Benefit) of -$4.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-29
- REPLIGEN CORP deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $2.92M.
- REPLIGEN CORP deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$7.70M.
- REPLIGEN CORP deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $2.41M.
- REPLIGEN CORP deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$3.21M.
- REPLIGEN CORP deferred income tax expense (benefit) for fiscal 2025 was -$3.37M.
- REPLIGEN CORP deferred income tax expense (benefit) for fiscal 2024 was -$16.79M, a 1528.94% decline from fiscal 2023.
- REPLIGEN CORP deferred income tax expense (benefit) for fiscal 2023 was $1.18M.
- REPLIGEN CORP deferred income tax expense (benefit) for fiscal 2022 was -$1.35M, a 120.75% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$4.78M 10-Q · filed 2026-07-29 | -$2.36M derived: sum of 3 quarters · filed 2026-07-29 | -$5.58M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | -$7.70M 10-Q · filed 2026-05-06 | -$5.29M derived: sum of 2 quarters · filed 2026-05-06 | -$8.50M derived: sum of 3 quarters · filed 2026-05-06 | -$9.87M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $2.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$804.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.17M derived: sum of 3 quarters · filed 2026-07-29 | -$3.37M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$4.58M derived: sum of 2 quarters · filed 2026-07-29 | -$5.78M 10-Q · filed 2025-11-04 | -$18.41M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | -$1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$2.57M 10-Q · filed 2026-07-29 | -$15.20M derived: sum of 3 quarters · filed 2026-07-29 | -$15.61M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | -$1.20M 10-Q · filed 2026-05-06 | -$13.83M derived: sum of 2 quarters · filed 2026-05-06 | -$14.24M derived: sum of 3 quarters · filed 2026-05-06 | -$16.87M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$13.04M derived: sum of 2 quarters · filed 2026-02-26 | -$15.67M derived: sum of 3 quarters · filed 2026-02-26 | -$16.79M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$410.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$3.04M derived: sum of 2 quarters · filed 2025-11-04 | -$4.16M 10-Q · filed 2025-11-04 | $6.28M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.75M 10-Q · filed 2025-08-07 | -$2.63M 10-Q · filed 2024-07-30 | $6.69M derived: sum of 3 quarters · filed 2026-02-26 | -$525.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$1.12M 10-Q · filed 2025-04-29 | -$833.00K 10-Q · filed 2024-05-01 | $9.32M derived: sum of 2 quarters · filed 2026-02-26 | $2.11M derived: sum of 3 quarters · filed 2026-02-26 | $840.00K derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $10.44M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | $3.23M derived: sum of 2 quarters · filed 2026-02-26 | $1.96M derived: sum of 3 quarters · filed 2026-02-26 | $1.18M 10-K · filed 2026-02-26 | $2.32M 10-K · filed 2024-02-22 | |||
| 2023-09-30 | -$7.21M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$8.48M derived: sum of 2 quarters · filed 2024-11-18 | -$9.27M 10-Q/A · filed 2024-11-18 | -$9.76M 10-Q · filed 2023-10-31 | -$12.34M derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2023-06-30 | -$1.27M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$2.05M 10-Q/A · filed 2024-11-18 | -$2.20M 10-Q · filed 2023-08-02 | -$5.13M derived: sum of 3 quarters · filed 2025-03-14 | -$4.14M derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2023-03-31 | -$787.00K 10-Q/A · filed 2024-11-18 | -$1.12M 10-Q · filed 2023-05-02 | -$3.86M derived: sum of 2 quarters · filed 2025-03-14 | -$2.88M derived: sum of 3 quarters · filed 2025-03-14 | -$3.18M derived: sum of 4 quarters · filed 2025-03-14 | |||
| 2022-12-31 | -$3.07M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | -$2.09M derived: sum of 2 quarters · filed 2025-03-14 | -$2.40M derived: sum of 3 quarters · filed 2025-03-14 | -$1.35M 10-K · filed 2025-03-14 | ||||
| 2022-09-30 | $984.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $677.00K derived: sum of 2 quarters · filed 2024-11-18 | $1.72M 10-Q/A · filed 2024-11-18 | $2.17M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-06-30 | -$307.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $738.00K 10-Q/A · filed 2024-11-18 | $1.18M derived: sum of 3 quarters · filed 2024-11-18 | $1.99M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-03-31 | $1.04M 10-Q/A · filed 2024-11-18 | $1.49M derived: sum of 2 quarters · filed 2024-11-18 | $2.30M derived: sum of 3 quarters · filed 2024-11-18 | $6.77M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2021-12-31 | $446.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $1.25M derived: sum of 2 quarters · filed 2024-11-18 | $5.73M derived: sum of 3 quarters · filed 2024-11-18 | $6.52M 10-K/A · filed 2024-11-18 | ||||
| 2021-09-30 | $805.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $5.28M derived: sum of 2 quarters · filed 2022-11-01 | $6.07M 10-Q · filed 2022-11-01 | $2.01M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $5.27M 10-Q · filed 2022-08-02 | $1.20M derived: sum of 3 quarters · filed 2023-02-22 | $3.19M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $789.00K 10-Q · filed 2022-04-27 | -$3.27M derived: sum of 2 quarters · filed 2023-02-22 | -$1.29M derived: sum of 3 quarters · filed 2023-02-22 | |||||
| 2020-12-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$2.08M derived: sum of 2 quarters · filed 2023-02-22 | -$3.99M 10-K · filed 2023-02-22 | |||||
| 2020-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $72.00K 10-Q · filed 2021-10-28 | ||||||
| 2020-06-30 | -$1.91M 10-Q · filed 2021-07-27 | |||||||
| 2019-12-31 | $9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$1.51M derived: sum of 2 quarters · filed 2022-02-17 | -$1.52M derived: sum of 3 quarters · filed 2022-02-17 | -$624.00K 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | -$10.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$10.57M derived: sum of 2 quarters · filed 2020-11-05 | -$9.68M 10-Q · filed 2020-11-05 | -$10.08M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $889.00K 10-Q · filed 2020-07-30 | $488.00K derived: sum of 3 quarters · filed 2021-02-24 | $635.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $892.00K 10-Q · filed 2020-05-06 | $491.00K derived: sum of 2 quarters · filed 2021-02-24 | $638.00K derived: sum of 3 quarters · filed 2021-02-24 | $514.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$254.00K derived: sum of 2 quarters · filed 2021-02-24 | -$378.00K derived: sum of 3 quarters · filed 2021-02-24 | $71.00K 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $23.00K derived: sum of 2 quarters · filed 2019-10-31 | $472.00K 10-Q · filed 2019-10-31 | -$11.14M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $325.00K 10-Q · filed 2019-08-01 | -$11.29M derived: sum of 3 quarters · filed 2020-02-26 | -$18.97M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $449.00K 10-Q · filed 2019-05-09 | -$11.17M derived: sum of 2 quarters · filed 2020-02-26 | -$18.85M derived: sum of 3 quarters · filed 2020-02-26 | -$24.24M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | -$11.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$19.30M derived: sum of 2 quarters · filed 2020-02-26 | -$24.69M derived: sum of 3 quarters · filed 2020-02-26 | -$24.68M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | -$7.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$13.07M derived: sum of 2 quarters · filed 2018-11-01 | -$13.06M 10-Q · filed 2018-11-01 | -$17.48M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | -$5.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$5.38M 10-Q · filed 2018-08-02 | -$9.80M derived: sum of 3 quarters · filed 2019-03-01 | -$9.69M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $10.00K 10-Q · filed 2018-05-08 | -$4.41M derived: sum of 2 quarters · filed 2019-03-01 | -$4.30M derived: sum of 3 quarters · filed 2019-03-01 | |||||
| 2016-12-31 | -$4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$4.31M derived: sum of 2 quarters · filed 2019-03-01 | -$4.09M 10-K · filed 2019-03-01 | |||||
| 2016-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $326.00K 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | $218.00K 10-Q · filed 2017-08-03 | |||||||
| 2015-12-31 | -$336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$291.00K derived: sum of 2 quarters · filed 2018-02-22 | -$205.00K derived: sum of 3 quarters · filed 2018-02-22 | -$118.00K 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $131.00K derived: sum of 2 quarters · filed 2016-11-03 | $218.00K 10-Q · filed 2016-11-03 | $252.00K derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $173.00K 10-Q · filed 2016-08-04 | $173.10K 10-Q · filed 2015-08-06 | $207.00K derived: sum of 3 quarters · filed 2017-02-23 | $314.30K derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $87.00K 10-Q · filed 2016-05-05 | $86.55K 10-Q · filed 2015-05-08 | $121.00K derived: sum of 2 quarters · filed 2017-02-23 | $228.30K derived: sum of 3 quarters · filed 2017-02-23 | $374.43K derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $141.30K derived: sum of 2 quarters · filed 2017-02-23 | $287.43K derived: sum of 3 quarters · filed 2017-02-23 | $295.00K 10-K · filed 2017-02-23 | $295.10K 10-K · filed 2015-03-17 | |||
| 2014-09-30 | $107.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $253.43K derived: sum of 2 quarters · filed 2015-11-05 | $261.00K 10-Q · filed 2015-11-05 | $261.47K 10-Q · filed 2014-11-07 | $606.40K derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | $146.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $153.70K 10-Q · filed 2015-08-06 | $499.11K derived: sum of 3 quarters · filed 2016-02-25 | $1.95M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $7.57K 10-Q · filed 2015-05-08 | $352.97K derived: sum of 2 quarters · filed 2016-02-25 | $1.80M derived: sum of 3 quarters · filed 2016-02-25 | $2.91M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $345.40K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.80M derived: sum of 2 quarters · filed 2016-02-25 | $2.90M derived: sum of 3 quarters · filed 2016-02-25 | $2.79M 10-K · filed 2016-02-25 | $2.79M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.55M derived: sum of 2 quarters · filed 2014-11-07 | $2.44M 10-Q · filed 2014-11-07 | |||||
| 2013-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $992.86K 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | -$112.40K 10-Q · filed 2014-05-09 | |||||||
| 2012-12-31 | -$3.14M 10-K · filed 2015-03-17 | |||||||
| 2011-12-31 | $15.74K 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |